AI-generated summary
The authors evaluated 829 chemotherapy cycles in 112 children with cancer to examine how often oral mucositis occurred and which factors were linked to it. Oral mucositis was diagnosed in 63.57% of cycles, with higher incidence and severity under certain high-dose methotrexate protocols and with lower blood cell counts and higher liver and kidney markers. The authors describe these as associations in a single-center study, not proof of causation.
- Participants
- 112
- Who or what was studied
- Children and adolescents aged 0 to 17 years with childhood cancer (mostly leukemia, sarcomas and lymphomas) undergoing chemotherapy
- Limits stated in the abstract
- The abstract describes an observational analysis of chemotherapy cycles, so associations cannot establish cause and effect, and the abstract does not report the photobiomodulation outcomes or wavelengths used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Photobiomodulation therapy, Photobiomodulation, GRADE, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.